MoneyWorks4Me

Shree Ganesh Biotech (India) informs about disclosure

25 Feb 2023 Evaluate
Shree Ganesh Biotech (India) has informed that the Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Krishna Corporation.

The above information is a part of company’s filings submitted to BSE.

Peers